- New drugs in the treatment of B-lymphoproliferative disorders - highlights from ICML congress in Lugano, June 20132013 | Faculty of Medicine in Hradec Králové
- Report of University Hospital Hradec Králové to the clinical trial protocol No: GO28667Publication without faculty affiliation
- Final report of University Hospital Hradec Kralove to the clinical trial protocol no. GO28667Publication without faculty affiliation
- Targeting of BCL2 Family Proteins with ABT-199 and Homoharringtonine Reveals BCL2-and MCL1-Dependent Subgroups of Diffuse Large B-Cell Lymphoma2016 | First Faculty of Medicine, Second Faculty of Medicine
- New drugs for the treatment of chronic lymphocytic leukemia2015 | First Faculty of Medicine
- 3,5,7-Substituted Pyrazolo[4,3-d]pyrimidine Inhibitors of Cyclin-Dependent Kinases and Their Evaluation in Lymphoma Models2019 | First Faculty of Medicine, Faculty of Mathematics and Physics
- Anti-apoptotic MCL1 Protein Represents Critical Survival Molecule for Most Burkitt Lymphomas and BCL2-negative Diffuse Large B-cell Lymphomas2022 | First Faculty of Medicine
- Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trial2020 | Third Faculty of Medicine
- Genomics and drug profiling of fatal TCF3-HLF-positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options2015 | Second Faculty of Medicine
- Dimethyl fumarate induces ferroptosis and impairs NF-kappa B/STAT3 signaling in DLBCL2021 | First Faculty of Medicine
- Experimental therapy of B-cell Non-Hodgkin's lymphonasPublication without faculty affiliation